Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.
Severn Health Solutions, Severna Park, Maryland, USA.
J Fr Ophtalmol. 2022 Sep;45(7):756-761. doi: 10.1016/j.jfo.2022.01.004. Epub 2022 Jun 23.
A major cause of blindness in older persons is age-related macular degeneration (AMD). Cigarette smoking is one of the major risk factors for AMD. In the present study, we analyzed UK Biobank data to determine whether smoking cannabis, like cigarettes, might be related to AMD.
Our UK Biobank application was approved as UKB project 57245 (S.L., P.H.R.). Our analysis included all subjects with AMD and cannabis smoking information. The diagnosis of AMD was ascertained based on the 10th Revision of the International Classification of Diseases (ICD10), H35.3. Age at time of diagnosis of AMD was obtained from data field 5923. Cannabis information was recorded in UKB category 143, data field 20453, ever taken cannabis. A touch screen posed the question, "Have you taken CANNABIS (cannabis, grass, hash, ganja, blow, draw, skunk, weed, spliff, dope), even if it was a long time ago?" Possible answers were no, yes, 1-2 times, yes 3-10 times, yes, 11-100 times, yes, more than 100 times.
Subjects who had used marijuana more than 100 times had a significantly reduced risk of AMD, compared to subjects who had never used marijuana, and use of marijuana every day was associated with less AMD than use of marijuana less than once a month. But subjects who used cannabis 100 times or more were significantly younger (8years) when they developed AMD than subjects who never used cannabis.
Drusen, deposits of lipids, proteins, and cellular debris, accumulate in Bruch's membrane, limiting transport between the retinal pigment epithelium and the vasculature, triggering an inflammatory reaction. Marijuana can retard the inflammatory process because it is a powerful anti-inflammatory agent. Therefore, marijuana could reduce the risk of AMD. At the same time, blood vessels in the choriocapillaris below Bruch's membrane become more sparse with age. This phenomenon is believed to be a starting point for AMD. Marijuana can accelerate the loss of blood vessels due to its anti-angiogenic properties. Therefore, marijuana use might cause AMD to develop sooner in younger people.
老年人失明的一个主要原因是年龄相关性黄斑变性(AMD)。吸烟是 AMD 的主要危险因素之一。在本研究中,我们分析了英国生物库的数据,以确定像吸烟一样吸食大麻是否与 AMD 有关。
我们的英国生物库应用程序已被批准为 UKB 项目 57245(S.L.,P.H.R.)。我们的分析包括所有患有 AMD 和吸食大麻信息的受试者。AMD 的诊断是根据国际疾病分类第 10 版(ICD10),H35.3 确定的。AMD 诊断时的年龄从数据字段 5923 中获得。大麻信息记录在 UKB 类别 143 中,数据字段 20453 中,曾经吸食过大麻。触摸屏提出了一个问题,“你是否吸食过大麻(大麻、草、哈希、大麻、大麻、大麻、大麻、大麻),即使是很久以前?”可能的答案是不,是,1-2 次,是 3-10 次,是 11-100 次,是,超过 100 次。
与从未使用过大麻的受试者相比,使用大麻超过 100 次的受试者患 AMD 的风险显著降低,而每天使用大麻与 AMD 的发生频率低于每月使用大麻不到一次。但是,使用大麻 100 次或更多次的受试者在出现 AMD 时明显比从未使用过大麻的受试者年轻(8 岁)。
玻璃膜疣,脂质、蛋白质和细胞碎片的沉积物,在 Bruch 膜中积聚,限制了视网膜色素上皮和脉管系统之间的运输,引发炎症反应。大麻可以延缓炎症过程,因为它是一种强大的抗炎剂。因此,大麻可以降低 AMD 的风险。同时,Bruch 膜下方脉络膜毛细血管的血管随年龄的增长变得更加稀疏。这种现象被认为是 AMD 的一个起点。大麻因其抗血管生成特性可能加速血管的丧失。因此,大麻的使用可能会导致年轻人更早出现 AMD。